Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
7.18
-0.11 (-1.51%)
Apr 17, 2026, 3:00 PM CST

SHA:600222 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,7581,9362,0651,9451,602
Other Revenue
-5.24.9515.332.83
1,7581,9412,0701,9611,605
Revenue Growth (YoY)
-9.46%-6.21%5.57%22.20%13.23%
Cost of Revenue
1,2661,4411,5081,4921,148
Gross Profit
492.23500.1561.55468.4456.85
Selling, General & Admin
258.36307.58339.5317.51246.89
Research & Development
67.78100.89127.71116.5256.5
Other Operating Expenses
3.268.636.548.422.59
Operating Expenses
329.4424.2485.6476.27331.51
Operating Income
162.8375.975.94-7.87125.34
Interest Expense
--59.64-54.37-64.63-83.84
Interest & Investment Income
-6.372.172.226.74
Other Non Operating Income (Expenses)
-80.93-1.5110.8-1.56-2.46
EBT Excluding Unusual Items
81.921.1234.54-71.8445.78
Gain (Loss) on Sale of Investments
1.247.94-6.42-11.87-10.17
Gain (Loss) on Sale of Assets
-0.020.130.540.03-1.57
Asset Writedown
-5.62---0.15-29.9
Legal Settlements
----11.61-1.62
Other Unusual Items
-5.8814.3112.594.93
Pretax Income
77.5135.0742.96-82.857.45
Income Tax Expense
11.64-18.42-1.87-7.090.67
Earnings From Continuing Operations
65.8753.544.83-75.766.78
Minority Interest in Earnings
-5.87-2.97-1.273.56-0.78
Net Income
6050.5343.56-72.26
Net Income to Common
6050.5343.56-72.26
Net Income Growth
18.75%16.00%---79.50%
Shares Outstanding (Basic)
553556563562560
Shares Outstanding (Diluted)
553556563562560
Shares Change (YoY)
-0.63%-1.12%0.07%0.36%2.52%
EPS (Basic)
0.110.090.08-0.130.01
EPS (Diluted)
0.110.090.08-0.130.01
EPS Growth
19.49%17.31%---80.00%
Free Cash Flow
26.04-76.820.6-191.0360.58
Free Cash Flow Per Share
0.05-0.140.00-0.340.11
Dividend Per Share
-0.0280.018-0.010
Dividend Growth
-55.56%---37.50%
Gross Margin
28.00%25.76%27.13%23.89%28.47%
Operating Margin
9.26%3.91%3.67%-0.40%7.81%
Profit Margin
3.41%2.60%2.10%-3.68%0.37%
Free Cash Flow Margin
1.48%-3.96%0.03%-9.74%3.78%
EBITDA
214.83127.2127.2339.37169.33
EBITDA Margin
12.22%6.55%6.15%2.01%10.55%
D&A For EBITDA
51.9951.351.2947.2443.99
EBIT
162.8375.975.94-7.87125.34
EBIT Margin
9.26%3.91%3.67%-0.40%7.81%
Effective Tax Rate
15.02%---9.01%
Revenue as Reported
-1,9412,0701,9611,605
Advertising Expenses
-26.7835.7839.7824.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.